小结
定义
病史和查体
诊断性检查
治疗流程
贡献者
作者 查看所有
Professor of Medicine
Division of Liver Diseases
Mount Sinai Hospital
New York
NY
利益冲突披露
JA declares that he has no competing interests.Dr Jawad Ahmad would like to gratefully acknowledge Dr Brian L. Pearlman, the previous contributor to this monograph. BLP is on the speakers’ bureaus and serves as an advisor to Merck, Gilead, J&J, and AbbVie, and does contracted research with Boehringer Ingelheim, Tibotec/Janssen, Bristol-Myers Squibb, Gilead, and Merck. BLP is also an author of a number of references cited in this monograph. BLP wishes to acknowledge Chaithanya Mallikarjun, MD, for her help in writing the original version of the manuscript.
同行评议专家 查看所有
Assistant Professor
Digestive Disease and Liver Transplant
Yale University
CT
利益冲突披露
AL has participated in an advisory board meeting with Gilead and Janssen, and is a primary investigator for Merck’s C-Surfer trial.Director of Hepatology and Medical Director of Liver Transplantation
Associate Professor of Medicine
Strong Memorial Hospital
University of Rochester
NY
利益冲突披露
BM belongs to the paid speaker’s bureau for pharmaceutical companies Gilead (maker of ledipasvir/sofosbuvir), AbbVie (maker of Viekira Pak® - ombitasvir/paritaprevir/ritonavir and dasabuvir), Merck, and Salix.Consultant Hepatologist
Bradford Teaching Hospitals Foundation Trust
Bradford
UK
利益冲突披露
SM has received sponsorship and has sat on advisory boards for BMS, Gilead, AbbVie, and Merck.Consultant Hepatologist
Nottingham University Hospitals NHS Trust
UK
利益冲突披露
SR is an advisory board (paid) member for AbbVie, Gilead, Janssen, and MSD.
使用此内容应接受我们的免责声明。
